Equity research firm Zuanic & Associates led by senior analyst Pablo Zuanic has initiated coverage of Gold Flora (OTC: GRAM) with an Overweight rating.
Connecticut's Record Sales In December
Connecticut experienced a record-breaking December in 2023, with combined sales of adult-use cannabis and medical marijuana surpassing $27.5 million.
According to an SEC filing, Tilray entered into an assignment and assumption agreement with Double Diamond Holdings Ltd. (DDH) on Jan. 9. Tilray acquired a promissory note in the amount of $26,134,500.00 from DDH, and Tilray issued 12,386,019 shares of its common stock to DDH as consideration for the note.
Earlier this week, biopharma company Mind Medicine (MindMed) (NASDAQ: MNMD) released latest clinical trial results on repeated sub-perceptual doses of its LSD compound, MM-120, in adults with ADHD. The company also provided a corporate update and outlook for 2024.
In 2021, Ramiro Marra rose to political prominence by joining La Libertad Avanza, a party that now makes global headlines after winning the presidency in Argentina,
The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment.